For: | Wang D, Xiao M, Wan ZM, Lin X, Li QY, Zheng SS. Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges. World J Gastrointest Surg 2023; 15(4): 544-552 [PMID: 37206072 DOI: 10.4240/wjgs.v15.i4.544] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i4/544.htm |
Number | Citing Articles |
1 |
Mansour Bahardoust, Maryam Zolfaghari Dehkharghani, Pouya Ebrahimi, Maryam Najafirashed, Safa Mousavi, Meisam Haghmoradi, Mohsen Khaleghian, Adnan Tizmaghz. Effect of ABO blood group on postoperative overall survival and recurrence-free survival rate in patients with hepatocellular carcinoma after hepatectomy: a multi-center retrospective cohort study. BMC Surgery 2023; 23(1) doi: 10.1186/s12893-023-02236-8
|
2 |
Abhimati Ravikulan, Kamran Rostami. Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine. World Journal of Gastroenterology 2024; 30(5): 424-428 doi: 10.3748/wjg.v30.i5.424
Abstract(257) |
Core Tip(257) |
Full Article(HTML)(1430)
|
Full Article with Cover (PDF)-3548K(110)
|
Full Article (Word)-242K(21)
|
Audio-234K(8)
|
Peer-Review Report-224K(58)
|
Answering Reviewers-264K(46)
|
Full Article (PDF)-550K(96)
|
Full Article (XML)-38K(36)
|
Times Cited (1)
|
Total Visits (3398)
|
Open
|
3 |
Jianping Wang, Peipei Cong, Zhipeng Jin, Lingli Liu, Dongxu Sun, Wenjing Zhu, Guangjun Shi. A novel prognostic signature for hepatocellular carcinoma based on SUMOylation-related genes. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-38197-4
|
4 |
Xiaocheng Gong, Yunfei Liu, Keying Liang, Zixi Chen, Ke Ding, Li Qiu, Jinfen Wei, Hongli Du. Cucurbitacin I exerts its anticancer effects by inducing cell cycle arrest via the KAT2a-ube2C/E2F1 pathway and inhibiting HepG2-induced macrophage M2 polarization. Biochemical and Biophysical Research Communications 2024; 738: 150508 doi: 10.1016/j.bbrc.2024.150508
|